Cargando…

Low Expression of CLEC2B Indicates Poor Prognosis in Melanoma

BACKGROUND: Melanoma is a highly malignant skin tumor with a poor prognosis. Identification of novel biomarkers might potentially reveal the underlying mechanisms of melanoma progression. METHODS: We demonstrated the relationship between pan-cancer CLEC2B expression and melanoma samples in The Cance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yanqiu, Li, Yaling, Yan, Hongwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961593/ https://www.ncbi.nlm.nih.gov/pubmed/36851951 http://dx.doi.org/10.2147/CCID.S395854

Ejemplares similares

High expression levels of CLEC4M indicate poor prognosis in patients with hepatocellular carcinoma
por: Luo, Liuping, et al.
Publicado: (2020)

CLEC4M is associated with poor prognosis and promotes cisplatin resistance in NSCLC patients
por: Tan, Li-Ming, et al.
Publicado: (2019)

Overexpression of CLEC18B Associates With the Proliferation, Migration, and Prognosis of Glioblastoma
por: Guo, Rui-Ming, et al.
Publicado: (2018)

High Expression of CLEC11A Predicts Favorable Prognosis in Acute Myeloid Leukemia
por: Yin, Chengliang, et al.
Publicado: (2021)

Overexpression of CLEC3A promotes tumor progression and poor prognosis in breast invasive ductal cancer
por: Ni, Jun, et al.
Publicado: (2018)

Low Expression of Mir-137 Predicts Poor Prognosis in Cutaneous Melanoma Patients
por: Li, Nan
Publicado: (2016)

Low STYK1 expression indicates poor prognosis in gastric cancer
por: Fang, Jian, et al.
Publicado: (2018)

Low EIF2B5 expression predicts poor prognosis in ovarian cancer
por: Hou, Lin, et al.
Publicado: (2020)

High expression of UBD correlates with epirubicin resistance and indicates poor prognosis in triple-negative breast cancer
por: Han, Tao, et al.
Publicado: (2015)

CLEC2 and CLEC5A: Pathogenic Host Factors in Acute Viral Infections
por: Sung, Pei-Shan, et al.
Publicado: (2019)

High CLEC-2 expression associates with unfavorable postoperative prognosis of patients with clear cell renal cell carcinoma
por: Xiong, Ying, et al.
Publicado: (2016)

Increased Expression of CAP2 Indicates Poor Prognosis in Hepatocellular Carcinoma()()
por: Fu, Jia, et al.
Publicado: (2015)

Low expression of BMPRIB indicates poor prognosis of breast cancer and is insensitive to taxane-anthracycline chemotherapy
por: Dai, Kun, et al.
Publicado: (2015)

Low REST Expression Indicates a Biomarker of Poor Prognosis in Patients with Renal Cell Carcinoma
por: Lv, Chaoxiang, et al.
Publicado: (2021)

Platelet CLEC‐2 and lung development
por: Suzuki‐Inoue, Katsue, et al.
Publicado: (2020)

ZC3H15 Correlates with a Poor Prognosis and Tumor Progression in Melanoma
por: Li, Qian, et al.
Publicado: (2021)

High expression of DARS2 indicates poor prognosis in lung adenocarcinoma
por: Jiang, Yingfeng, et al.
Publicado: (2022)

High expression of TAZ indicates a poor prognosis in retinoblastoma
por: Zhang, Yiting, et al.
Publicado: (2015)

High Expression of Serine Hydroxymethyltransferase 2 Indicates Poor Prognosis of Gastric Cancer Patients
por: Shi, Haihong, et al.
Publicado: (2019)

High expression of cluster of differentiation 276 indicates poor prognosis in glioma
por: Li, Linchen, et al.
Publicado: (2021)

Low-dose Btk inhibitors selectively block platelet activation by CLEC-2
por: Nicolson, Phillip L.R., et al.
Publicado: (2020)

Positive expression of ZNF689 indicates poor prognosis of hepatocellular carcinoma
por: Yi, Peng Sheng, et al.
Publicado: (2018)

The Role of CLEC-2 and Its Ligands in Thromboinflammation
por: Meng, Danyang, et al.
Publicado: (2021)

Decreased expression of hyaluronan synthase 1 and 2 associates with poor prognosis in cutaneous melanoma
por: Poukka, Mari, et al.
Publicado: (2016)

CLEC3B as a Potential Prognostic Biomarker in Hepatocellular Carcinoma
por: Xie, Xing-Wei, et al.
Publicado: (2021)

High expression of fibronectin 1 indicates poor prognosis in gastric cancer
por: Sun, Yang, et al.
Publicado: (2020)

High USP22 expression indicates poor prognosis in hepatocellular carcinoma
por: Tang, Bo, et al.
Publicado: (2015)

CLEC1B Expression and PD-L1 Expression Predict Clinical Outcome in Hepatocellular Carcinoma with Tumor Hemorrhage()()
por: Hu, Kuan, et al.
Publicado: (2018)

Low expression of ryanodine receptor 2 is associated with poor prognosis in thyroid carcinoma
por: Xu, Nizhen, et al.
Publicado: (2019)

Podoplanin-expressing inflammatory macrophages activate murine platelets via CLEC-2
por: Kerrigan, A M, et al.
Publicado: (2012)

High G2 and S‐phase expressed 1 expression promotes acral melanoma progression and correlates with poor clinical prognosis
por: Xu, Tianxiao, et al.
Publicado: (2018)

Upregulation of Serum miR-10b Is Associated with Poor Prognosis in Patients with Melanoma
por: Bai, Ming, et al.
Publicado: (2017)

Co-expression of Piwil2/Piwil4 in nucleus indicates poor prognosis of hepatocellular carcinoma
por: Zeng, Guangping, et al.
Publicado: (2016)

D-Dimer and Prothrombin Time Are the Significant Indicators of Severe COVID-19 and Poor Prognosis
por: Long, Hui, et al.
Publicado: (2020)

Increased expression of protease-activated receptors 2 indicates poor prognosis in HBV related hepatocellular carcinoma
por: Chen, Peng, et al.
Publicado: (2019)

Podoplanin and CLEC-2 levels in patients with COVID-19
por: Borba-Junior, Ivanio Teixeira, et al.
Publicado: (2023)

PDGF upregulates CLEC-2 to induce T regulatory cells
por: Agrawal, Sudhanshu, et al.
Publicado: (2015)

The podoplanin-CLEC-2 axis inhibits inflammation in sepsis
por: Rayes, Julie, et al.
Publicado: (2017)

Extracellular vesicles from CLEC2-activated platelets enhance dengue virus-induced lethality via CLEC5A/TLR2
por: Sung, Pei-Shan, et al.
Publicado: (2019)

Loss of IL-34 Expression Indicates Poor Prognosis in Patients With Lung Adenocarcinoma
por: Wang, Zhendong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mmb70opcn1i774vn5cddqns7d5